Company at a glance
Scale
Revenue up 74% since FY2023
Growth prospects
Expanding customer base and product roadmap
via sse.com.cn ↗Passed STAR Market listing committee 2022-11-16; listed on SSE STAR Market (688627) in 2023via money.finance.sina.com.cn ↗Reported as exclusive domestic supplier of HBM test machines to top memory customer CXMT (长鑫存储); FT tester orders received from February 2025; CP and…Official filings: static.sse.com.cn ↗ · static.sse.com.cn ↗ · Sina Finance — FY2025 annual report ↗
All sourced facts (9)
- Listing status: Shanghai Stock Exchange (SSE) · 001168 · A-shares
- Founded: 2011-05-31 in Shenzhen (Longhua district); national high-tech enterprise and national 'little giant' (专精特新小巨人) via seichitech.com ↗
- IPO: Passed STAR Market listing committee 2022-11-16; listed on SSE STAR Market (688627) in 2023 via sse.com.cn ↗
- Strategy: Dual-wheel strategy: new-display (AMOLED) inspection equipment plus semiconductor memory test equipment for DRAM wafer test, final test and aging repair via seichitech.com ↗
- Key products: DRAM CP (wafer) test machines, FT (final) test machines and aging-repair systems; S9880 high-speed final-test system; sockets/boards and probe cards; customized HBM test solutions via money.finance.sina.com.cn ↗
- CXMT relationship: Reported as exclusive domestic supplier of HBM test machines to top memory customer CXMT (长鑫存储); FT tester orders received from February 2025; CP and high-speed FT production units placed at customer fabs via money.finance.sina.com.cn ↗
- FY2025 results: Revenue RMB 1.128 billion (+40.46% YoY); net profit RMB 65.42 million (-18.39%); semiconductor test equipment grew +151.31% YoY to 55.51% of main revenue, overtaking display inspection via money.finance.sina.com.cn ↗
- Growth targets: Equity-incentive targets: 2025 revenue growth ≥60% with semiconductor business growth ≥500%; 2026 revenue growth ≥110% via stcn.com ↗
- H1 2026: Revenue RMB 804 million (+81.17% YoY); net profit RMB 48.9 million (+59.9%); memory test equipment revenue +147.05% YoY via m.10jqka.com.cn ↗
About
Designs and sells semiconductor memory test equipment (DRAM CP/FT testers, HBM test solutions, burn-in/repair), sockets and probe cards, plus AMOLED new-display inspection and repair equipment; revenue concentrated in top memory makers led by CXMT.
Founded 2011 · Ticker 001168
Why it matters
Jingzhida is China's principal domestic supplier of DRAM/HBM test equipment at exactly the moment CXMT scales DRAM and HBM capacity; breaking the ~70% share of foreign ATE giants (Advantest/Teradyne) in memory test is a key localization milestone for China's memory expansion.
Where it sits in the stack
Key semiconductor products
- DRAM memory test equipmentCP wafer testers, FT final testers (S9880 high-speed system), aging and repair systems
- HBM test solutions·TSV-precision, high-bandwidth customized testers
- Sockets, burn-in boards and probe cards
- AMOLED new-display inspection and calibration-repair equipment
Financials
688627.SS · Shanghai Stock Exchange STAR Market 688627.SS · via Yahoo Finance ↗
Financial trajectory via annual filings via Yahoo Finance
RMB billionsMarket data refreshed daily; annual figures from exchange filings. Figures in the reporting currency shown on the chart.
Ecosystem
Global peer set
- Advantest
- Teradyne
- Horiba (domestic peer context)
Competitive position
- Leading domestic challenger to Advantest/Teradyne in memory ATE, attacking roughly 70% foreign share in the segment
- Exclusive reported domestic HBM tester supplier to CXMT as China's HBM capacity scales
- Memory test overtook AMOLED inspection as its largest business in 2025
- Global comparables: Advantest
- Global comparables: Teradyne
- Global comparables: Horiba (domestic peer context)
Milestones and signals
- 2011—Jingzhida (精智达) was founded.
- 2025—Memory Test Share Of Main Revenue: CNY 55.51% (+151.31% YoY)
- 2026-10-04—Market cap: RMB 43.0B
- FY2025—Revenue: RMB 1.1B
- FY2025—Net Profit: RMB 65.4M
- Listing—Shanghai Stock Exchange (SSE) · 001168 · A-shares
What to watch
- Order flow tied to CXMT DRAM/HBM capacity expansion
- Progress toward 2026 revenue growth target (≥110%)
- Margin pressure: profit fell in FY2025 despite revenue growth
- Broadening beyond single-anchor-customer dependence
Questions
Last reviewed 2026-07-11Answered questions
What is the measurable gap versus global reference companies?
Leading domestic challenger to Advantest/Teradyne in memory ATE, attacking roughly 70% foreign share in the segment.
Open questions
- Which products are qualified beyond pilots in equipment?
- Which customers, fabs, or end markets show real adoption rather than policy interest?